Impact of the COVID-19 pandemic on acute coronary syndromes

Autor: Sophie Degrauwe, Elena Tessitore, Marco Roffi, Juan F. Iglesias, Lamyae Benzakour, François Mach, Murat Cimci, Stéphane Noble, Florian Rey, Nils Perrin
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
medicine.medical_specialty
medicine.medical_treatment
Acute Coronary Syndrome/epidemiology/surgery
Comorbidity
Time-to-Treatment/statistics & numerical data
Rate ratio
Time-to-Treatment
03 medical and health sciences
ddc:616.89
0302 clinical medicine
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention/statistics & numerical data
Medicine
Humans
030212 general & internal medicine
Myocardial infarction
cardiovascular diseases
Acute Coronary Syndrome
Pandemics
Aged
COVID-19/epidemiology
Retrospective Studies
ddc:616
business.industry
SARS-CoV-2
Incidence (epidemiology)
Percutaneous coronary intervention
COVID-19
Retrospective cohort study
General Medicine
Length of Stay
Middle Aged
medicine.disease
Troponin/blood
Confidence interval
Troponin
Out-of-Hospital Cardiac Arrest/epidemiology/therapy
ST Elevation Myocardial Infarction/epidemiology/therapy
Emergency medicine
Conventional PCI
ST Elevation Myocardial Infarction
Female
business
030217 neurology & neurosurgery
Out-of-Hospital Cardiac Arrest
Zdroj: Swiss Medical Weekly, Vol. 150 (2020) P. w20448
ISSN: 1424-7860
Popis: AIM To assess the impact of the first wave of the COVID-19 pandemic on acute coronary syndromes and on the delay from symptom onset to first medical contact among patients presenting with ST-segment elevation myocardial infarction (STEMI), as well as to investigate whether there were patient-related reasons related to COVID-19 for delaying first medical contact. METHODS AND RESULTS All patients undergoing percutaneous coronary intervention (PCI) at the Geneva University Hospitals for acute coronary syndromes (ACS) during the first COVID-19 wave were compared with a control group consisting of all ACS patients who underwent PCI during the same period in 2019 and those treated in the period immediately preceding the pandemic. The primary outcome measure was the difference in the delay from symptom onset to first medical contact in the setting of STEMI between the COVID-19 period and the control period. Secondary outcome measures were the difference in ACS incidence and the impact of the COVID-19 pandemic on patients’ decisions to call the emergency services, assessed using a questionnaire. Delay from symptom onset to first medical contact was longer among patients suffering from STEMI in the COVID-19 period compared with the control period (112 min vs 60 min, p = 0.049). The incidence rate of ACS was lower during the COVID-19 period (incidence rate ratio 0.6, 95% confidence interval [CI] 0.449–0.905). ACS patients delayed their call to the emergency services mainly because of fear of contracting or spreading COVID-19 following hospital admission, as well as of adding burden to the healthcare system. CONCLUSION We observed prolonged delays from symptom onset to first medical contact and a decline in overall ACS incidence during the first wave of the COVID-19 pandemic, with a higher threshold to call for help among ACS patients.
Databáze: OpenAIRE